GOBELLO-Jan PV-SA Review
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
1997 Asa Program.Pdf
Friday, February 21 12:00 NOON- 11:00 PM Executive Council Meeting (lunch and supper served) (Chesapeake Room NB) Saturday, February 22 8:00-9:40 AM Postgraduate Course (Constellation 3:00-5:00 PM Postgraduate Course (Constellation Ballroom A) Ballroom A) 9:40-1 0:00 AM Refreshment Break 6:00-7:00 PM Student Mixer (Maryland Suites-Balti 10:00-12:00 NOON Postgraduate Course (Constellation more Room) Ballroom A) 7:00-9:00 PM ASA Welcoming Reception (Atrium 12:00-1 :00 PM Lunch (on your own) Lobby) 7:00-9:00 PM Exhibits Open (Constellation Ball I :00-2:40 PM Postgraduate Course (Constellation Ballroom A) rooms E, F) 2:40-3:00 PM Refreshment Break 9:00- 1 I :00 PM Executive Council Meeting (Chesa peake Room NB) Sunday, February 23 7:45-8:00 AM Welcome and Opening Remarks 12:00-1 :30 PM Women in Andrology Luncheon (Ches (Constellation Ballroom A) apeake Room NB) 8:00-9:00 AM Serono Lecture: "Genetics of Prostate Business Meeting 12:00-12:30 Cancer" Patrick Walsh (Constellation Speaker and Lunch 12:30-1:30 Ballroom A) I :30-3:00 PM Symposium I: "Regulation of Testicu 9:00-10:00 AM American Urological Association Lec lar Growth and Function" (Constellation ture: "New Medical Treatments of Im Ballroom A) potence" Irwin Goldstein (Constella Patricia Morris tion Ballroom A) Martin Matzuk 10:00-10:30 AM Refreshment Break/Exhibits 3:00-3:30 PM Refreshment Break/Exhibits (Constellation Ballrooms E, F) (Constellation Ballrooms E, F) 10:30-12:00 NOON Oral Session I: "Genes and Male Repro 3:30-4:30 PM Oral Session II: "Calcium Channels duction" (Constellation Ballroom A) and Male Reproduction" (Constellation Ballroom A) 12:00- 1 :30 PM Lune (on your own) � 4:30-6:30 PM Poster Session I (Constellation Ball �4·< rooms C, D) \v\wr 7:30-11:00 PM Banquet (National Aquarium) Monday, February 24 7:00-8:00 AM Past Presidents' Breakfast 12:00-1 :30 PM Simultaneous Events: (Pratt/Calvert Rooms) I. -
Seminal Vesicles in Autosomal Dominant Polycystic Kidney Disease
Chapter 18 Seminal Vesicles in Autosomal Dominant Polycystic Kidney Disease Jin Ah Kim1, Jon D. Blumenfeld2,3, Martin R. Prince1 1Department of Radiology, Weill Cornell Medical College & New York Presbyterian Hospital, New York, USA; 2The Rogosin Institute, New York, USA; 3Department of Medicine, Weill Cornell Medical College, New York, USA Author for Correspondence: Jin Ah Kim MD, Department of Radiology, Weill Cornell Medical College & New York Presbyterian Hospital, New York, USA. Email: [email protected] Doi: http://dx.doi.org/10.15586/codon.pkd.2015.ch18 Copyright: The Authors. Licence: This open access article is licenced under Creative Commons Attribution 4.0 International (CC BY 4.0). http://creativecommons.org/licenses/by/4.0/ Users are allowed to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material for any purpose, even commercially), as long as the author and the publisher are explicitly identified and properly acknowledged as the original source. Abstract Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD) have been known to involve male reproductive organs, including cysts in testis, epididymis, seminal vesicles, and prostate. The reported prevalence of seminal vesicle cysts in patients with ADPKD varies widely, from 6% by computed tomography (CT) to 21%–60% by transrectal ultrasonography. However, seminal vesicles in ADPKD that are dilated, with a diameter greater than 10 mm by magnetic resonance imaging (MRI), are In: Polycystic Kidney Disease. Xiaogang Li (Editor) ISBN: 978-0-9944381-0-2; Doi: http://dx.doi.org/10.15586/codon.pkd.2015 Codon Publications, Brisbane, Australia. -
Aspermia: a Review of Etiology and Treatment Donghua Xie1,2, Boris Klopukh1,2, Guy M Nehrenz1 and Edward Gheiler1,2*
ISSN: 2469-5742 Xie et al. Int Arch Urol Complic 2017, 3:023 DOI: 10.23937/2469-5742/1510023 Volume 3 | Issue 1 International Archives of Open Access Urology and Complications REVIEW ARTICLE Aspermia: A Review of Etiology and Treatment Donghua Xie1,2, Boris Klopukh1,2, Guy M Nehrenz1 and Edward Gheiler1,2* 1Nova Southeastern University, Fort Lauderdale, USA 2Urological Research Network, Hialeah, USA *Corresponding author: Edward Gheiler, MD, FACS, Urological Research Network, 2140 W. 68th Street, 200 Hialeah, FL 33016, Tel: 305-822-7227, Fax: 305-827-6333, USA, E-mail: [email protected] and obstructive aspermia. Hormonal levels may be Abstract impaired in case of spermatogenesis alteration, which is Aspermia is the complete lack of semen with ejaculation, not necessary for some cases of aspermia. In a study of which is associated with infertility. Many different causes were reported such as infection, congenital disorder, medication, 126 males with aspermia who underwent genitography retrograde ejaculation, iatrogenic aspemia, and so on. The and biopsy of the testes, a correlation was revealed main treatments based on these etiologies include anti-in- between the blood follitropine content and the degree fection, discontinuing medication, artificial inseminization, in- of spermatogenesis inhibition in testicular aspermia. tracytoplasmic sperm injection (ICSI), in vitro fertilization, and reconstructive surgery. Some outcomes were promising even Testosterone excreted in the urine and circulating in though the case number was limited in most studies. For men blood plasma is reduced by more than three times in whose infertility is linked to genetic conditions, it is very difficult cases of testicular aspermia, while the plasma estradiol to predict the potential effects on their offspring. -
Brucella Abortus Epididymo-Orchitis Relapsing in the Opposite Testis After Three Months
‹nfeksiyon Dergisi (Turkish Journal of Infection) 2003; 17 (1): 95-98 BRUCELLA ABORTUS EPIDIDYMO-ORCHITIS RELAPSING IN THE OPPOSITE TESTIS AFTER THREE MONTHS ÜÇ AY SONRA KARfiI TEST‹STE TEKRARLAYAN BRUCELLA ABORTUS EP‹D‹D‹MO-ORfi‹T‹ Esragül AKINCI1 Hürrem BODUR1 Çi¤dem ERBAY1 Mehmet DEVEER2 Numune Training and Research Hospital, Ankara 1 Department of Clinical Microbiology and Infectious Diseases 2 Department of Radiology Key Words: Brucellosis, Brucella abortus, orchitis, epididymitis, epididymo-orchitis, relapse Anahtar Sözcükler: Bruselloz, Brucella abortus, orflit, epididimit, epididimo-orflit, relaps SUMMARY Epididymo-orchitis caused by Brucella species is a rare infection. In this article, a 47-year-old man with relaps of Brucella abortus epididymo-orchitis in the opposite testis is presented. Testicular atrophy and aspermia occurred in the patient despite antibiotic therapy. ÖZET Brucella türlerinin neden oldu¤u epididimo-orflit ender görülen bir infeksiyondur. Bu yaz›da, karfl› testisinde tekrarlayan Brucella abortus epididimo-orflitli 47 yafl›nda bir olgu sunulmufltur. Antibiyotik tedavisine karfl›n hastada testis atrofisi ve aspermi geliflmifltir. On physical examination the left hemiscrotum was tender, INTRODUCTION hyperaemic and enlarged greatly. He had a fever of Epididymo-orchitis is a rare manifestation of brucellosis. 38.4¡ C, white blood cell count 17.000/mm3, erythrocyte Brucella species cause granulomatous orchitis usually sedimentation rate 49 mm/h, and CRP 136 mg/l (normal: presenting as an acute or chronic unilateral swelling of <5 mg/l). Urine analysis and liver function tests were the testis (1). Brucellosis is an endemic disease in Turkey. normal. No growth was detected in the ejaculate and In this case report, a patient with Brucella abortus urine cultures. -
Male Fertility Following Spinal Cord Injury: a Guide for Patients Second Edition
Male Fertility Following Spinal Cord Injury: A Guide For Patients Second Edition By Nancy L. Brackett, Ph.D., HCLD Emad Ibrahim, M.D. Charles M. Lynne, M.D. 1 2 This is the second edition of our booklet. The first was published in 2000 to respond to a need in the spinal cord injured (SCI) community for a source of information about male infertility. At that time, we were getting phone calls almost daily on the subject. Today, we continue to get numerous requests for information, although these requests now arrive more by internet than phone. These requests, combined with numerous hits on our website, attest to the continuing need for dissemination of this information to the SCI community as well as to the medical community. “The more things change, the more they stay the same.” This quote certainly holds true for the second edition of our booklet. In the current age of advanced reproductive technologies, numerous avenues for help are available to couples with male partners with SCI. Although the help is available, we have learned from our patients as well as our professional colleagues that not all reproductive medicine specialists are trained in managing infertility in couples with SCI male partners. In some cases, treatments are offered that may be unnecessary. It is our hope that the information contained in this updated edition of our booklet can be used as a talking point for patients and their medical professionals. The Male Fertility Research Program of the Miami Project to Cure Paralysis is known around the world for research and clinical efforts in the field of male infertility in the SCI population. -
A Complication of Brucellosis: Epididymoorchitis
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector International Journal of Infectious Diseases (2006) 10, 171—177 http://intl.elsevierhealth.com/journals/ijid A complication of brucellosis: Epididymoorchitis Esragu¨l Akıncı a,*,Hu¨rrem Bodur a, Mustafa Aydın C¸evik a, Ays¸e Erbay a, Selim Sırrı Eren a,I˙pek Zıraman b, Neriman Balaban c, Ali Atan d,Gu¨lu¨s¸an Ergu¨l e a Department of Infectious Diseases and Clinical Microbiology, Ankara Numune Education and Research Hospital, Ankara, Turkey b Department of Radiology, Ankara Numune Education and Research Hospital, Ankara, Turkey c Department of Microbiology, Ankara Numune Education and Research Hospital, Ankara, Turkey d Department of Urology, Ankara Numune Education and Research Hospital, Ankara, Turkey e Department of Pathology, Ankara Numune Education and Research Hospital, Ankara, Turkey Received 18 October 2004; received in revised form 28 January 2005; accepted 24 February 2005 Corresponding Editor: Marguerite Neill, Pawtucket, USA KEYWORDS Summary Brucellosis; Brucella mellitensis; Background: Epididymoorchitis is the most frequent genitourinary complication of Brucella abortus; brucellosis. Epididymoorchitis; Methods: This prospective study was conducted between February 2001 and January Genitourinary 2004, prospectively. Male patients diagnosed with brucellosis were included in this infections study and evaluated for testicular involvement. Results: Epididymoorchitis was detected in 17 out of 134 (12.7%) male patients with brucellosis. Mean age of the patients was 36.9 Æ 7.1 years. Twelve patients (70.6%) had acute, four patients (23.5%) had subacute, and one patient (5.9%) had chronic brucellosis. The most common symptoms were scrotal pain (94%) and swelling (82%). -
Infertility in the Male Dog - a Diagnostic Approach [Infertilidade No Cão - Abordagem Clínica]
Congresso de Ciências Veterinárias [Proceedings of the Veterinary Sciences Congress, 2002], SPCV, Oeiras, 10-12 Out., pp. 171-176 Animais de Companhia Infertility in the male dog - A diagnostic approach [Infertilidade no cão - Abordagem clínica] Stefano Romagnoli Introduction Infertility in the male dog can which has a normal libido and is able to mount can be due to lack of or incomplete ejaculation or to poor semen quality. Infertility due to inability to mount or to low libido may or may not be a reproductive issue (it is often an orthopedic or a behavioral problem) and will not be discussed here. Ejaculation problems Failure of or incomplete ejaculation may occur if the coital lock is not adequate because of fright or discomfort during mating or at semen collection. Ejaculation may sometimes occur retrogradely into the bladder if there is an incompetence of the internal urethral sphincter muscle Retrograde ejaculation - The ejaculatory process is coordinated by sympathetic and parasympathetic nervous activity, and is divided into seminal emission (the deposition of semen from the vasa deferentia and accessory sex glands into the prostatic urethra) and ejaculation (passage of semen through the uretra and outside through the external urethral orifice). During ejaculation the bladder neck contracts, thus playing an important role in preventing a retrograde flux of spermatozoa into the bladder. Vasa deferentia and bladder neck are primarily under the control of the sympathetic nervous system. Alfa-adrenoceptor stimulation causes contraction of the vas deferens, while beta- adrenoceptor stimulation mediates relaxation of the vas deferens. The use of alfa-adrenergic agonists increases seminal emission: for example, administration of xylazine (alfa-2 adrenoceptor agonist) in the dog causes increased contraction of vasa deferentia and decreased urethral pressure, thereby facilitating passage of spermatozoa into the bladder (not associated to ejaculation). -
Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline Part II Peter N
Diagnosis and treatment of infertility in men: AUA/ASRM guideline part II Peter N. Schlegel, M.D.,a Mark Sigman, M.D.,b Barbara Collura,c Christopher J. De Jonge, Ph.D, H.C.L.D.(A.B.B.),d Michael L. Eisenberg, M.D.,e Dolores J. Lamb, Ph.D., H.C.L.D.(A.B.B.),f John P. Mulhall, M.D.,g Craig Niederberger, M.D., F.A.C.S.,h Jay I. Sandlow, M.D.,i Rebecca Z. Sokol, M.D., M.P.H.,j Steven D. Spandorfer, M.D.,f Cigdem Tanrikut, M.D., F.A.C.S.,k Jonathan R. Treadwell, Ph.D.,l Jeffrey T. Oristaglio, Ph.D.,l and Armand Zini, M.D.m a New York Presbyterian Hospital-Weill Cornell Medical College; b Brown University; c RESOLVE; d University of Minnesota School of Medicine; e Stanford University School of Medicine; f Weill Cornell Medical College; g Memorial-Sloan Kettering Cancer Center; h Weill Cornell Medicine, University of Illinois-Chicago School of Medicine; i Medical College of Wisconsin; j University of Southern California School of Medicine; k Georgetown University School of Medicine; l ECRI; and m McGill University School of Medicine Purpose: The summary presented herein represents Part II of the two-part series dedicated to the Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline. Part II outlines the appropriate management of the male in an infertile couple. Medical therapies, surgical techniques, as well as use of intrauterine insemination (IUI)/in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) are covered to allow for optimal patient management. -
Laboratory Assessment of Male Infertility—A Guide for the Urologist
Infertility Laboratory Assessment of Male Infertility—A Guide for the Urologist Ashok Agarwal, PhD, Frances Monette Bragais, MD and Edmund S Sabanegh, Jr, MD Center for Reproductive Medicine, Glickman Urological and Kidney Institute, Cleveland Clinic Abstract After receiving a thorough history-taking and physical exam, patients should have two to three properly collected semen analyses. Semen analysis is a demanding test requiring laboratory personnel who are well trained in all aspects of andrological examination. To ensure the highest level of accuracy in andrology testing, clinicians should refer their patients to diagnostic laboratories that are accredited by national organizations (such as the College of American Pathologists [CAP] in the US) and subscribe to external proficiency testing schemes in andrology as part of their quality management. Specialized andrology laboratory tests may be ordered as indicated to properly diagnose male factor infertility. These tests include fructose test in azoospermic samples, viability test for poor motility specimen, antisperm antibody test in cases of agglutination and poor motility, peroxidase test for white blood cells in cases of infection or inflammation, tests for seminal reactive oxygen species level, and total antioxidant capacity in seminal plasma; sperm DNA fragmentation assessment may be helpful in cases of idiopathic male factor. Keywords Semen analysis, male infertility, sperm morphology, DNA damage, oxidative stress, andrology Disclosure: The authors have no conflicts of interest to declare. Received: September 22, 2008 Accepted: November 3, 2008 Correspondence: Ashok Agarwal, PhD, Center for Reproductive Medicine, Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk A19.1, Cleveland, OH 44195. E: [email protected] The assessment of a male’s fertility starts with a thorough history-taking retrograde ejaculation. -
Examination and Processing of Human Semen
WHO laboratory manual for the Examination and processing of human semen FIFTH EDITION WHO laboratory manual for the Examination and processing of human semen FIFTH EDITION WHO Library Cataloguing-in-Publication Data WHO laboratory manual for the examination and processing of human semen - 5th ed. Previous editions had different title : WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 1.Semen - chemistry. 2.Semen - laboratory manuals. 3.Spermatozoa - laboratory manuals. 4.Sperm count. 5.Sperm-ovum interactions - laboratory manuals. 6.Laboratory techniques and procedures - standards. 7.Quality control. I.World Health Organization. ISBN 978 92 4 154778 9 (NLM classifi cation: QY 190) © World Health Organization 2010 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications— whether for sale or for noncommercial distribution—should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expres- sion of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specifi c companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. -
Infertility & ART Sub Fertility
Infertility & ART Sub fertility Dr. Kakali Saha MBBS, FCPS,MS (Obs & Gynae) Associate professor dept. Of Obs & Gynae Medical college for women & hospital Definition • Infertility is defined as the inability of a couple to achieve conception after 1 year of unprotected coitus. • Sub fertility is another commonly used term by infertility specialist. • Sterility is an absolute state of inability to conceive. • Childless is not infertility Frequency of conception • The fecundability of a normal couple has been estimated 20-25% • About 90% of couples conceive after 12 months of regular unprotected intercourse. ✦ 50-60% will conceive in 3 months ✦ 70% will concave in 6 months. Types or classification • Primary infertility -when couple never conceived before • Secondary infertility -when the same states developing after an initial phase of fertility A concept of fertility • Before puberty • After puberty & before maturation • Fertility usually low until the age of 16-17 years • During pregnancy • Dring lactation • After menopause Causes of infertility According to Jeffcoate’s • Female factors - 40% • Male factors - 35% • Combined -10-20% • Unexplained -rest Causes of infertility Now a days observe by infertility specialist • Causes of female factors Male factors • Assessment of male factors Abnormal semen • Aspermia -No semen • Hypospermia -volume <2ml • Hyperspermia - volume >2ml • Azoospermia - no spermatozoa in semen • Oligospermia <20 million sperm/ml • Polyzoospermia - >250 million sperm/ml • Asthenospermia - decrease motility (<25%) • Teratozoospermia - >50% abnormal spermatozoa in semen • Necrospermia - motility 0% ART • Assisted reproductive technology is not new includes medical procedures used primarily to address infertility. This subject involves procedures such as in vitro fertilisation, intracytoplasmic sperm injection (ICSI), cryopreservation of gametes or embryos, and or use of fertility medications. -
Ketotifen, a Mast Cell Blocker Improves Sperm Motility in Asthenospermic Infertile Men
Original Article Ketotifen, a mast cell blocker improves sperm motility in asthenospermic infertile men ABSTRACT Nasrin Saharkhiz, Roshan Nikbakht1, AIM: This study aimed to evaluate the efficacy of ketotifen on sperm motility of Masoud Hemadi1 asthenospermic infertile men. SETTING AND DESIGN: It is a prospective study designed Infertility and In Vitro in vivo. MATERIALS AND METHODS: In this interventional experimental study, a Fertilization Center, Taleghani Hospital, total of 40 infertile couples with asthenospermic infertility factor undergoing assisted Shahid Beheshti University reproductive technology (ART) cycles were enrolled. The couples were randomly assigned of Medical Sciences, to one of two groups at the starting of the cycle. In control group (n = 20), the men did not Tehran, Iran, 1Fertility, receive Ketotifen, while in experiment group (n = 20), the men received oraly ketotifen Infertility and Perinatology Research Center, (1 mg Bid) for 2 months. Semen analysis, under optimal circumferences, was obtained prior School of Medicine, to initiation of treatment. The second semen analysis was done 2-3 weeks after stopped Ahvaz Jundishapur University ketotifen treatment and sperm motility was defined. Clinical pregnancy was identified as of Medical Sciences, the presence of a fetal sac by vaginal ultrasound examination. STATISTICAL ANALYSIS Ahvaz, Iran USED: All data are expressed as the mean ± standard error of mean (SEM). t test was Address for correspondence: used for comparing the data of the control and treated groups. RESULTS: The mean Dr. Masoud Hemadi, sperm motility increased significantly (from 16.7% to 21.4%) after ketotifen treatment Fertility, Infertility, and (P < 0.001). This sperm motility improvement was more pronounced in the primary Perinatology Research Center, School of Medicine, infertility cases (P < 0.003).